Mahiben Maruthappu

Maruthappu was born in London in 1988. He studied preclinical medicine at Selwyn College, Cambridge, where he graduated with a triple first class,[8] and as a student ran several charities, including CONTACT and Medic to Medic. He studied clinical medicine at Green Templeton College, Oxford and in his fifth year founded the United Kingdom Medical Students' Association (UKMSA), which provided free educational resources to over 40,000 students.[2] He was also a Kennedy Scholar in Global Health at Harvard University, where he conducted research at Harvard's Center for Surgery and Public Health.[9]

Maruthappu began his career as a physician at Ealing Hospital in 2013. He later practised at Chelsea & Westminster Hospital NHS Foundation Trust and then trained in Public Health.[10] In 2014, he was appointed scholar at National Institute for Health and Care Excellence, where he focused on the use of structured feedback in surgery.[8]

in 2014 Maruthappu became the first appointed Senior Fellow to the Chief Executive Officer of NHS England, Simon Stevens.[11][12]

Whilst at the NHS, Maruthappu advised on innovation, technology and prevention, and in 2015, he co-founded the NHS Innovation Accelerator (NIA), a programme aimed at spreading technologies across the health service, that also led to the development of the first NHS Innovation Tariff, a national reimbursement mechanism for medical technologies and digital health products.[13][4][14] Maruthappu has been described as the “whizzkid helping save the NHS”.[7]

He co-founded the NHS's £450 million Workplace Wellness Programme and the Diabetes Prevention Programme (DPP), which as of 2017 had been rolled out to half of the population in England.[15]  He led NHS England's contribution to the Government's Childhood Obesity Plan and originated the NHS Sugar Tax, which preceded the UK Government’s Soft Drinks Industry Levy and so-called Sugar Tax.[16]

After his mother fell and fractured part of her back, Maruthappu faced difficulties in arranging required home care.[17] He subsequently co-founded Cera,[18] a social care provider that uses an on-demand digital platform to match people seeking in-home assistance with professional carers, allowing families to keep updated on a patient's progress, while also using Artificial Intelligence to predict potential health deteriorations in patients.[19][20]

Under Maruthappu, within 3 years Cera reached over 6,000 employees, 20 offices, and 30,000 care visits being delivered a day, while securing over $90 million of financing, making Cera one of the largest health technology companies in Europe.[21] [22]

Maruthappu is an associate Board Member of Imperial College Healthcare NHS Trust, one of the largest NHS Trusts in the country, with £GBP 1.2 billion turnover, and a Board Member of Skills for Care, the national body for the UK’s 1.5 million care workforce.[23][24] He is also a member of the advisory board for HealthTechDigital[25][26] He was a Founding Board Member of Digital Health London.[27]

He writes for The Guardian and Forbes, and has lectured undergraduate students at Cambridge University since the age of 20.[28][29][30]

Maruthappu’s research focuses on public health, innovation and health economics.

He subsequently partook in the ‘landmark’ 2018 study demonstrating that health & social care funding constraints in England were linked to 120,000 excess deaths; a so called ‘mortality gap’.[31][32] The study called for over £20 billion of additional investment into the health and care system.[33][34]

• Maruthappu M. Sugandh K. Medical School: The Applicant’s Guide, Doctors Academy Ltd., 2013 and 2010, ISBN 9380573278
• Maruthappu M. Sugandh K. Medical School: The Undergraduate’s Guide Doctors Academy Ltd., 2013 ISBN 9380573286

• Forbes' 30 under 30[3]
• LaingBuisson Rising Star[35]
• Financial Times Top 10 most influential BAME tech leaders in UK[36]
• Wired Top 10 Innovators in Healthcare[37]
• 2017 Technology Leader Award (Disruptive Leader of the Year)[38]

• Cera
• NHS UK
• UKMSA